Skip to content

Viemed Healthcare, Inc. VMD Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
ResMed logo
ResMedRMD
UFP Technologies logo
UFP TechnologiesUFPT
Solventum logo
SolventumSOLV
iRadimed logo
iRadimedIRMD
ICU Medical logo
ICU MedicalICUI

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Cash & equivalents$9.8M-3.9%
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$448.16M+71.3%
Enterprise value$450.83M+74.6%
P/E30.1×+8.8×
P/S1.6×+0.4×

Profitability

See full
Gross margin57.6%-1.1pp
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp
FCF margin9%

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Where this comes from

Reported directly by Viemed Healthcare, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s common stock, shares, outstanding?
Viemed Healthcare, Inc. (VMD) reported common stock, shares, outstanding of $38.53M in Q1 2026.
How has Viemed Healthcare, Inc.'s common stock, shares, outstanding changed year-over-year?
Viemed Healthcare, Inc.'s common stock, shares, outstanding decreased by 2.5% year-over-year, from $39.52M to $38.53M.
What is the long-term trend for Viemed Healthcare, Inc.'s common stock, shares, outstanding?
Over 5 years (2020 to 2025), Viemed Healthcare, Inc.'s common stock, shares, outstanding has grown at a -0.6% compound annual growth rate (CAGR), from $39.19M to $38.02M.